Probe into spurious blood-pressure drug expands to manufacturing network

The Haryana Food and Drugs Administration’s investigation into suspected spurious blood-pressure tablets has reportedly expanded to the manufacturing and supply network, resulting in further arrests. A joint search with the Delhi Drugs Control Department also uncovered an unlicensed stockist and recovered additional suspected spurious tablets.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.